Apyx Medical Corp Research and Development Expense
Apyx Medical Corp (APYX) reported Research and Development Expense of $793.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- Apyx Medical Corp research and development expense for the quarter ending 2026-06-30 was $793.00K, a 3.76% decline year-over-year.
- Apyx Medical Corp research and development expense for the quarter ending 2026-03-31 was $765.00K, a 4.85% decline year-over-year.
- Apyx Medical Corp research and development expense for the quarter ending 2025-12-31 was $944.00K, a 15.49% decline year-over-year.
- Apyx Medical Corp research and development expense for the quarter ending 2025-09-30 was $801.00K, a 29.86% decline year-over-year.
- Apyx Medical Corp research and development expense for fiscal 2025 was $3.37M, a 33.60% decline from fiscal 2024.
- Apyx Medical Corp research and development expense for fiscal 2024 was $5.08M, a 6.62% decline from fiscal 2023.
- Apyx Medical Corp research and development expense for fiscal 2023 was $5.44M, a 19.72% increase from fiscal 2022.
- Apyx Medical Corp research and development expense for fiscal 2022 was $4.54M, a 5.16% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $793.00K 10-Q · filed 2026-08-06 | $1.56M 10-Q · filed 2026-08-06 | $2.50M derived: sum of 3 quarters · filed 2026-08-06 | $3.30M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $765.00K 10-Q · filed 2026-05-07 | $1.71M derived: sum of 2 quarters · filed 2026-05-07 | $2.51M derived: sum of 3 quarters · filed 2026-05-07 | $3.33M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $944.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.75M derived: sum of 2 quarters · filed 2026-03-10 | $2.57M derived: sum of 3 quarters · filed 2026-08-06 | $3.37M 10-K · filed 2026-03-10 | ||||
| 2025-09-30 | $801.00K 10-Q · filed 2025-11-06 | $1.63M derived: sum of 2 quarters · filed 2026-08-06 | $2.43M 10-Q · filed 2025-11-06 | $3.55M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $824.00K 10-Q · filed 2026-08-06 | $1.63M 10-Q · filed 2026-08-06 | $2.75M derived: sum of 3 quarters · filed 2026-08-06 | $3.89M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $804.00K 10-Q · filed 2026-05-07 | $1.92M derived: sum of 2 quarters · filed 2026-05-07 | $3.06M derived: sum of 3 quarters · filed 2026-05-07 | $4.49M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $2.26M derived: sum of 2 quarters · filed 2026-03-10 | $3.68M derived: sum of 3 quarters · filed 2026-03-10 | $5.08M 10-K · filed 2026-03-10 | ||||
| 2024-09-30 | $1.14M 10-Q · filed 2025-11-06 | $2.57M derived: sum of 2 quarters · filed 2025-11-06 | $3.96M 10-Q · filed 2025-11-06 | $5.37M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $1.42M 10-Q · filed 2025-08-07 | $2.82M 10-Q · filed 2025-08-07 | $4.22M derived: sum of 3 quarters · filed 2025-08-07 | $5.63M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $1.40M 10-Q · filed 2025-05-08 | $2.80M derived: sum of 2 quarters · filed 2025-05-08 | $4.21M derived: sum of 3 quarters · filed 2025-05-08 | $5.57M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $2.81M derived: sum of 2 quarters · filed 2025-03-13 | $4.17M derived: sum of 3 quarters · filed 2025-03-13 | $5.44M 10-K · filed 2025-03-13 | $4.84M 10-K · filed 2024-03-21 | |||
| 2023-09-30 | $1.41M 10-Q · filed 2024-11-08 | $1.28M 10-Q · filed 2023-11-09 | $2.77M derived: sum of 2 quarters · filed 2024-11-08 | $4.04M 10-Q · filed 2024-11-08 | $3.60M 10-Q · filed 2023-11-09 | $5.29M derived: sum of 4 quarters · filed 2024-11-08 | ||
| 2023-06-30 | $1.36M 10-Q · filed 2024-08-08 | $1.20M 10-Q · filed 2023-08-11 | $2.63M 10-Q · filed 2024-08-08 | $2.32M 10-Q · filed 2023-08-11 | $3.88M derived: sum of 3 quarters · filed 2024-08-08 | $4.94M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $1.27M 10-Q · filed 2024-05-09 | $1.12M 10-Q · filed 2023-05-11 | $2.53M derived: sum of 2 quarters · filed 2024-05-09 | $3.59M derived: sum of 3 quarters · filed 2024-05-09 | $4.66M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $2.32M derived: sum of 2 quarters · filed 2024-03-21 | $3.39M derived: sum of 3 quarters · filed 2024-03-21 | $4.54M 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | $1.06M 10-Q · filed 2023-11-09 | $2.13M derived: sum of 2 quarters · filed 2023-11-09 | $3.29M 10-Q · filed 2023-11-09 | $4.24M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $1.07M 10-Q · filed 2023-08-11 | $2.23M 10-Q · filed 2023-08-11 | $3.17M derived: sum of 3 quarters · filed 2023-08-11 | $4.35M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $1.16M 10-Q · filed 2023-05-11 | $2.10M derived: sum of 2 quarters · filed 2023-05-11 | $3.28M derived: sum of 3 quarters · filed 2023-05-11 | $4.36M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $947.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $2.12M derived: sum of 2 quarters · filed 2023-03-16 | $3.21M derived: sum of 3 quarters · filed 2023-03-16 | $4.32M 10-K · filed 2023-03-16 | ||||
| 2021-09-30 | $1.18M 10-Q · filed 2022-11-10 | $2.26M derived: sum of 2 quarters · filed 2022-11-10 | $3.37M 10-Q · filed 2022-11-10 | $4.29M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $1.08M 10-Q · filed 2022-08-11 | $2.20M 10-Q · filed 2022-08-11 | $3.12M derived: sum of 3 quarters · filed 2022-08-11 | $4.16M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $1.11M 10-Q · filed 2022-05-12 | $2.03M derived: sum of 2 quarters · filed 2022-05-12 | $3.08M derived: sum of 3 quarters · filed 2022-05-12 | $4.05M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $918.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $1.97M derived: sum of 2 quarters · filed 2022-03-17 | $2.94M derived: sum of 3 quarters · filed 2022-03-17 | $3.92M 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | $1.05M 10-Q · filed 2021-11-12 | $2.02M derived: sum of 2 quarters · filed 2021-11-12 | $3.00M 10-Q · filed 2021-11-12 | $4.10M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $975.00K 10-Q · filed 2021-08-12 | $1.96M 10-Q · filed 2021-08-12 | $3.05M derived: sum of 3 quarters · filed 2021-08-12 | $4.07M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $980.00K 10-Q · filed 2021-05-12 | $2.08M derived: sum of 2 quarters · filed 2021-05-12 | $3.09M derived: sum of 3 quarters · filed 2021-05-12 | $3.98M derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $2.11M derived: sum of 2 quarters · filed 2021-03-31 | $3.00M derived: sum of 3 quarters · filed 2021-03-31 | $3.73M 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $1.02M 10-Q · filed 2020-11-09 | $936.00K 10-Q · filed 2019-11-15 | $1.90M derived: sum of 2 quarters · filed 2020-11-09 | $2.63M 10-Q · filed 2020-11-09 | $3.29M derived: sum of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | $888.00K 10-Q · filed 2020-08-10 | $1.62M 10-Q · filed 2020-08-10 | $1.70M 10-Q · filed 2019-08-07 | $2.28M derived: sum of 3 quarters · filed 2020-08-10 | $2.89M derived: sum of 4 quarters · filed 2020-08-10 | |||
| 2019-03-31 | $730.00K 10-Q · filed 2020-05-11 | $810.00K 10-Q · filed 2019-05-08 | $1.39M derived: sum of 2 quarters · filed 2020-05-11 | $2.00M derived: sum of 3 quarters · filed 2020-05-11 | $2.77M derived: sum of 4 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $659.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-03-31 | $1.27M derived: sum of 2 quarters · filed 2020-05-08 | $2.04M derived: sum of 3 quarters · filed 2020-05-08 | $2.55M 10-K · filed 2020-03-31 | $2.47M 10-K · filed 2019-03-14 | |||
| 2018-09-30 | $613.00K 10-Q/A · filed 2020-05-08 | $1.38M derived: sum of 2 quarters · filed 2020-05-08 | $1.89M 10-Q/A · filed 2020-05-08 | $2.23M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-06-30 | $763.00K 10-Q · filed 2019-08-07 | $816.00K 10-Q · filed 2018-08-01 | $1.28M 10-Q · filed 2019-08-07 | $1.38M 10-Q · filed 2018-08-01 | $1.62M derived: sum of 3 quarters · filed 2020-05-08 | $2.10M derived: sum of 4 quarters · filed 2020-05-08 | ||
| 2018-03-31 | $514.00K 10-Q/A · filed 2020-05-08 | $562.00K 10-Q · filed 2018-05-15 | $855.00K derived: sum of 2 quarters · filed 2020-05-08 | $1.34M derived: sum of 3 quarters · filed 2020-05-08 | $2.04M derived: sum of 4 quarters · filed 2020-05-08 | |||
| 2017-12-31 | $341.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-03-31 | $828.00K derived: sum of 2 quarters · filed 2020-05-08 | $1.52M derived: sum of 3 quarters · filed 2020-05-08 | $1.94M 10-K · filed 2020-03-31 | $2.46M 10-K · filed 2018-03-13 | |||
| 2017-09-30 | $487.00K 10-Q/A · filed 2020-05-08 | $610.00K 10-Q · filed 2017-11-03 | $1.18M derived: sum of 2 quarters · filed 2020-05-08 | $1.60M 10-Q/A · filed 2020-05-08 | $2.02M 10-Q · filed 2017-11-03 | $984.00K derived: sum of 4 quarters · filed 2020-05-08 | ||
| 2017-06-30 | $696.00K 10-Q · filed 2018-08-01 | $1.41M 10-Q · filed 2018-08-01 | $497.00K derived: sum of 3 quarters · filed 2019-03-14 | $1.18M derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2017-03-31 | $709.00K 10-Q · filed 2018-05-15 | -$199.00K derived: sum of 2 quarters · filed 2019-03-14 | $482.00K derived: sum of 3 quarters · filed 2019-03-14 | $1.07M derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2016-12-31 | -$908.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$227.00K derived: sum of 2 quarters · filed 2019-03-14 | $365.00K derived: sum of 3 quarters · filed 2019-03-14 | $1.03M 10-K · filed 2019-03-14 | $2.62M 10-K · filed 2017-03-10 | |||
| 2016-09-30 | $681.00K 10-Q · filed 2017-11-03 | $682.00K 10-Q · filed 2016-10-27 | $1.27M derived: sum of 2 quarters · filed 2017-11-03 | $1.94M 10-Q · filed 2017-11-03 | $2.57M derived: sum of 4 quarters · filed 2018-03-13 | |||
| 2016-06-30 | $592.00K 10-Q · filed 2017-08-03 | $1.26M 10-Q · filed 2017-08-03 | $1.89M derived: sum of 3 quarters · filed 2018-03-13 | $2.47M derived: sum of 4 quarters · filed 2018-03-13 | ||||
| 2016-03-31 | $668.00K 10-Q · filed 2017-05-15 | $1.29M derived: sum of 2 quarters · filed 2018-03-13 | $1.88M derived: sum of 3 quarters · filed 2018-03-13 | $2.38M derived: sum of 4 quarters · filed 2018-03-13 | ||||
| 2015-12-31 | $626.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $1.21M derived: sum of 2 quarters · filed 2018-03-13 | $1.71M derived: sum of 3 quarters · filed 2018-03-13 | $2.16M 10-K · filed 2018-03-13 | ||||
| 2015-09-30 | $583.00K 10-Q · filed 2016-10-27 | $1.09M derived: sum of 2 quarters · filed 2016-10-27 | $1.53M 10-Q · filed 2016-10-27 | $1.93M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2015-06-30 | $505.00K 10-Q · filed 2016-08-02 | $951.00K 10-Q · filed 2016-08-02 | $1.35M derived: sum of 3 quarters · filed 2017-03-10 | $1.72M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2015-03-31 | $446.00K 10-Q · filed 2016-05-11 | $843.00K derived: sum of 2 quarters · filed 2017-03-10 | $1.21M derived: sum of 3 quarters · filed 2017-03-10 | $1.53M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2014-12-31 | $397.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $765.00K derived: sum of 2 quarters · filed 2017-03-10 | $1.08M derived: sum of 3 quarters · filed 2017-03-10 | $1.42M 10-K · filed 2017-03-10 | ||||
| 2014-09-30 | $368.00K 10-Q · filed 2015-11-05 | $686.00K derived: sum of 2 quarters · filed 2015-11-05 | $1.02M 10-Q · filed 2015-11-05 | $1.34M derived: sum of 4 quarters · filed 2016-03-18 | ||||
| 2014-06-30 | $318.00K 10-Q · filed 2015-08-07 | $651.00K 10-Q · filed 2015-08-07 | $972.00K derived: sum of 3 quarters · filed 2016-03-18 | $1.26M derived: sum of 4 quarters · filed 2016-03-18 | ||||
| 2014-03-31 | $332.00K 10-Q · filed 2015-05-08 | $654.00K derived: sum of 2 quarters · filed 2016-03-18 | $945.00K derived: sum of 3 quarters · filed 2016-03-18 | $1.26M derived: sum of 4 quarters · filed 2016-03-18 | ||||
| 2013-12-31 | $322.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-18 | $613.00K derived: sum of 2 quarters · filed 2016-03-18 | $927.00K derived: sum of 3 quarters · filed 2016-03-18 | $1.26M 10-K · filed 2016-03-18 | ||||
| 2013-09-30 | $291.00K 10-Q · filed 2014-11-10 | $605.00K derived: sum of 2 quarters · filed 2014-11-10 | $938.00K 10-Q · filed 2014-11-10 | $1.30M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $314.00K 10-Q · filed 2014-08-08 | $647.00K 10-Q · filed 2014-08-08 | $1.01M derived: sum of 3 quarters · filed 2015-02-27 | $1.33M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $333.00K 10-Q · filed 2014-05-15 | $693.00K derived: sum of 2 quarters · filed 2015-02-27 | $1.01M derived: sum of 3 quarters · filed 2015-02-27 | $1.36M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | $360.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $682.00K derived: sum of 2 quarters · filed 2015-02-27 | $1.03M derived: sum of 3 quarters · filed 2015-02-27 | $1.33M 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | $322.00K 10-Q · filed 2013-11-14 | $671.00K derived: sum of 2 quarters · filed 2013-11-14 | $969.00K 10-Q · filed 2013-11-14 | $1.24M derived: sum of 4 quarters · filed 2014-05-08 | ||||
| 2012-06-30 | $349.00K 10-Q/A · filed 2013-09-25 | $647.00K 10-Q/A · filed 2013-09-25 | $920.00K derived: sum of 3 quarters · filed 2014-05-08 | $1.21M derived: sum of 4 quarters · filed 2014-05-08 | ||||
| 2012-03-31 | $298.00K 10-Q · filed 2013-05-15 | $571.00K derived: sum of 2 quarters · filed 2014-05-08 | $859.00K derived: sum of 3 quarters · filed 2014-05-08 | $1.15M derived: sum of 4 quarters · filed 2014-05-08 | ||||
| 2011-12-31 | $273.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-05-08 | $561.00K derived: sum of 2 quarters · filed 2014-05-08 | $850.00K derived: sum of 3 quarters · filed 2014-05-08 | $1.20M 10-K/A · filed 2014-05-08 | ||||
| 2011-09-30 | $288.00K 10-Q · filed 2012-11-14 | $577.00K derived: sum of 2 quarters · filed 2012-11-14 | $924.00K 10-Q · filed 2012-11-14 | $1.31M derived: sum of 4 quarters · filed 2013-04-01 | ||||
| 2011-06-30 | $289.00K 10-Q · filed 2012-08-14 | $635.00K 10-Q · filed 2012-08-14 | $1.02M derived: sum of 3 quarters · filed 2013-04-01 | $1.47M derived: sum of 4 quarters · filed 2013-04-01 | ||||
| 2011-03-31 | $347.00K 10-Q · filed 2012-05-15 | $735.00K derived: sum of 2 quarters · filed 2013-04-01 | $1.18M derived: sum of 3 quarters · filed 2013-04-01 | $1.70M derived: sum of 4 quarters · filed 2013-04-01 | ||||
| 2010-12-31 | $388.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $830.00K derived: sum of 2 quarters · filed 2013-04-01 | $1.35M derived: sum of 3 quarters · filed 2013-04-01 | $1.85M 10-K · filed 2013-04-01 | ||||
| 2010-09-30 | $442.00K 10-Q · filed 2011-11-14 | $967.00K derived: sum of 2 quarters · filed 2011-11-14 | $1.47M 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | $525.00K 10-Q · filed 2011-08-12 | $1.02M 10-Q · filed 2011-08-12 | ||||||
| 2009-12-31 | $2.08M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |